Funk M. Integrating mental health into primary care: a global perspective. Geneva: World Health Organization; 2008.
Google Scholar
Kazadi N, Moosa M, Jeenah F. Factors associated with relapse in schizophrenia. S Afr J Psychiatry. 2008;14(2):52–62.
Google Scholar
Adebiyi MO, Mosaku SK, Irinoye OO, Oyelade OO. Socio-demographic and clinical factors associated with relapse in mental illness. Int J Africa Nurs Sci. 2018;8:149–53.
Google Scholar
Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry. 2004;184(4):346–51.
Article
PubMed
Google Scholar
Chaurotia V, Verma K, Baniya B. A study of psychosocial factor related with relapse in schizophrenia. IOSR-JDMS. 2016;15(4):26–34.
Google Scholar
Kane JM. Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry. 2007;68:27–30.
PubMed
Google Scholar
Capdevielle D, Boulenger J, Villebrun D, Ritchie K. Schizophrenic patients’ length of stay: mental health care implication and medicoeconomic consequences. L’Encephale. 2009;35(4):394–9.
Article
CAS
PubMed
Google Scholar
Papakostas S, Dar A, Ratna L. Sociodemographic factors and medication administration factors affecting re-hospitalization in patients with schizophrenia-spectrum disorders. Psychiatric Q. 2020. https://doi.org/10.1007/s11126-020-09756-z.
Article
Google Scholar
Csernansky JG, Schuchart EK. Relapse and rehospitalisation rates in patients with schizophrenia. CNS Drugs. 2002;16(7):473–84.
Article
PubMed
Google Scholar
Weret ZS, Mukherjee R. Prevalence of relapse and associated factors in patient with schizophrenia at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia: institution based cross sectional study. IJIMS. 2014;2(1):184–92.
Google Scholar
Bergé D, Mané A, Salgado P, Cortizo R, Garnier C, Gomez L, et al. Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study. Psychiatr Serv. 2016;67(2):227–33.
Article
PubMed
Google Scholar
Addington DE, Patten SB, McKenzie E, Addington J. Relationship between relapse and hospitalization in first-episode psychosis. Psychiatr Serv. 2013;64(8):796–9.
Article
PubMed
Google Scholar
Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull. 1998;24(1):75–85.
Article
CAS
PubMed
Google Scholar
Alvarez-Jimenez M, Priede A, Hetrick S, Bendall S, Killackey E, Parker A, et al. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2012;139(1–3):116–28.
Article
CAS
PubMed
Google Scholar
Porcelli S, Bianchini O, De Girolamo G, Aguglia E, Crea L, Serretti A. Clinical factors related to schizophrenia relapse. Int J Psychiatry Clin Pract. 2016;20(2):54–69.
Article
CAS
PubMed
Google Scholar
Hong J, Windmeijer F, Novick D, Haro JM, Brown J. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(5):835–41.
Article
PubMed
Google Scholar
Pompili M, Amador XF, Girardi P, Harkavy-Friedman J, Harrow M, Kaplan K, et al. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry. 2007;6(1):10.
Article
PubMed
PubMed Central
Google Scholar
Pigott TA, Carson WH, Saha AR, Torbeyns AR, Stock EG, Ingenito GG. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. J Clin Psychiatry. 2003. https://doi.org/10.4088/jcp.v64n0910.
Article
PubMed
Google Scholar
Fikreyesus M, Soboka M, Feyissa GT. Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study. BMC Psychiatry. 2016;16(1):354.
Article
PubMed
PubMed Central
Google Scholar
Mahamba ND. Factors influencing relapse of psychiatric outpatients in the rural communities of the Eastern Cape Province. South Africa: University of South Africa; 2009.
Google Scholar
Ayano G, Duko B. Relapse and hospitalization in patients with schizophrenia and bipolar disorder at the St Amanuel mental specialized hospital, Addis Ababa, Ethiopia: a comparative quantitative cross-sectional study. Neuropsychiatr Dis Treat. 2017;13:1527.
Article
PubMed
PubMed Central
Google Scholar
Fikreyesus M, Soboka M, Feyissa GT. Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study. BMC Psychiatry. 2016;16(1):1–10.
Article
Google Scholar
Caton CL, Hasin DS, Shrout PE, Drake RE, Dominguez B, Samet S, et al. Predictors of psychosis remission in psychotic disorders that co-occur with substance use. Schizophr Bull. 2006;32(4):618–25.
Article
PubMed
PubMed Central
Google Scholar
Thompson K, Kulkarni J, Sergejew A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241–7.
Article
CAS
PubMed
Google Scholar
Hogan TP, Awad A, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177–83.
Article
CAS
PubMed
Google Scholar
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.
Article
CAS
PubMed
Google Scholar
Perkins DO. Adherence to antipsychotic medications. J Clin Psychiatry. 1999;60:25–30.
PubMed
Google Scholar
Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100(1–3):53–9.
Article
PubMed
Google Scholar
Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PLoS ONE. 2015;10(3):e0120560.
Article
PubMed
PubMed Central
CAS
Google Scholar
Endale Gurmu A, Abdela E, Allele B, Cheru E, Amogne B. Rate of nonadherence to antipsychotic medications and factors leading to nonadherence among psychiatric patients in Gondar University Hospital Northwest Ethiopia. Adv Psychiatry. 2014. https://doi.org/10.1155/2014/475812.
Article
Google Scholar
Waddell L, Taylor M. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol. 2008;22(3):238–43.
Article
CAS
PubMed
Google Scholar
Dalgard OS, Dowrick C, Lehtinen V, Vazquez-Barquero JL, Casey P, Wilkinson G, et al. Negative life events, social support and gender difference in depression. Soc Psychiatry Psychiatr Epidemiol. 2006;41(6):444–51.
Article
PubMed
Google Scholar
Menberu M, Mekonen T, Azale T, Ayano G, Yimer S, Getnet A, et al. Health care seeking behavior for depression in Northeast Ethiopia: depression is not considered as illness by more than half of the participants. Ann Gen Psychiatry. 2018;17(1):34.
Article
PubMed
PubMed Central
Google Scholar
Zewdu S, Hanlon C, Fekadu A, Medhin G, Teferra S. Treatment gap, help-seeking, stigma and magnitude of alcohol use disorder in rural Ethiopia. Subst Abuse Treat Prev Policy. 2019;14(1):4.
Article
PubMed
PubMed Central
Google Scholar
Azale T, Fekadu A, Hanlon C. Treatment gap and help-seeking for postpartum depression in a rural African setting. BMC Psychiatry. 2016;16(1):196.
Article
PubMed
PubMed Central
Google Scholar
Brugha T, Bebbington PE, Tennant C, Hurry J. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15:189–94.
Article
CAS
PubMed
Google Scholar
Fekadu A, et al. Population level mental distress in rural Ethiopia. BMC Psychiatry. 2014;14:194.
Article
PubMed
PubMed Central
Google Scholar
Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med. 2007. https://doi.org/10.25011/cim.v30i1.447.
Article
PubMed
Google Scholar
Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess. 2000;12(2):186.
Article
CAS
PubMed
Google Scholar
French MT, Roebuck MC, McGeary KA, Chitwood DD, McCoy CB. Using the drug abuse screening test (DAST-10) to analyze health services utilization and cost for substance users in a community-based setting. Subst Use Misuse. 2001;36(6–7):927–43.
Article
CAS
PubMed
Google Scholar
Cocco KM, Carey KB. Psychometric properties of the drug abuse screening test in psychiatric outpatients. Psychol Assess. 1998;10(4):408.
Article
Google Scholar
Evren C, Can Y, Yilmaz A, Ovali E, Cetingok S, Karabulut V, et al. Psychometric properties of the drug abuse screening test (DAST-10) in heroin dependent adults and adolescents with drug use disorder. Dusunen Adam. 2013;26(4):351–9.
Article
Google Scholar
Onifade PBA, Abiodun O, Sotunsa J, Ladipo O. psychometric properties of alcohol smoking and substance involvement screening test (Assist V3. 0) among University Students. J Addict Behav Ther Rehabil. 2014;3(3):72.
Article
Google Scholar
Turkington A, Mulholland CC, Rushe TM, Anderson R, McCaul R, Barrett SL, et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry. 2009;195(3):242–8.
Article
PubMed
Google Scholar
Chaurotia VK, Verma K, Baniya GC. A study of psychosocial factor related with relapse in schizophrenia. IOSR J Dent Med Sci Ver XIV. 2016;15(4):2279–861.
Google Scholar
Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21(3):419–29.
Article
CAS
PubMed
Google Scholar
Winton-Brown TT, Elanjithara T, Power P, Coentre R, Blanco-Polaina P, McGuire P. Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis. Schizophr Res. 2017;179:50–6.
Article
PubMed
Google Scholar
Zipursky RB, Menezes NM, Streiner DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res. 2014;152(2–3):408–14.
Article
PubMed
Google Scholar
Schoeler T, Petros N, Di Forti M, Klamerus E, Foglia E, Murray R, et al. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. Lancet Psychiatry. 2017;4(8):627–33.
Article
PubMed
PubMed Central
Google Scholar
Ahmad I, Khalily MT, Hallahan B, Shah I. Factors associated with psychotic relapse in patients with schizophrenia in a Pakistani cohort. Int J Ment Health Nurs. 2017;26(4):384–90.
Article
PubMed
Google Scholar
Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev. 2020;9(1):1–18.
Article
Google Scholar
Teferra S, Hanlon C, Beyero T, Jacobsson L, Shibre T. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry. 2013;13(1):1–9.
Article
Google Scholar
Kane JM, Kishimoto T, Correll CU. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry. 2013;12(3):216–26.
Article
PubMed
PubMed Central
Google Scholar
Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. Adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(suppl 4):1–48.
PubMed
Google Scholar
Ahmad I, Khalily MT, Hallahan B. Reasons associated with treatment non-adherence in schizophrenia in a Pakistan cohort. Asian J Psychiatr. 2017;30:39–43.
Article
PubMed
Google Scholar
Beards S, Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C. Life events and psychosis: a review and meta-analysis. Schizophr Bull. 2013;39(4):740–7.
Article
PubMed
PubMed Central
Google Scholar
Hussein HA, Jacoob S, Sharour LA. Impact of life events on the relapse of schizophrenic patients. J Educ Pract. 2016;7(10):40–7.
Google Scholar
Biliaminu A, Aina J. Assessment of factors associated with treatment relapse among patients diagnosed with psychotic illness in two psychiatric hospitals in South west, Nigeria. Assessment. 2020;3(5):12–53.
Google Scholar
Taj F, Tanwir M, Aly Z, Khowajah AA, Tariq A, Syed FK, et al. Factors associated with non-adherence among psychiatric patients at a tertiary care hospital, Karachi, Pakistan: a questionnaire based cross-sectional study. J Pak Med Assoc . 2008;58(8):432.
PubMed
Google Scholar
Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8(3):232–41.
Article
CAS
PubMed
Google Scholar
Montes JM, Maurino J, de Dios C, Medina E. Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning. Patient Prefer Adherence. 2013;7:89.
PubMed
PubMed Central
Google Scholar
Hui CL, Tang JY, Leung C-M, Wong GH, Chang W-C, Chan SK, et al. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong. Aust N Z J Psychiatry. 2013;47(8):746–53.
Article
PubMed
Google Scholar
Addington D, Jean Addington M, Patten S. Relapse rates in an early psychosis treatment service. Acta Psychiatr Scand. 2007;115(2):126–31.
Article
CAS
PubMed
Google Scholar
Tiihonen J, Tanskanen A, Taipale H. 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia. Am J Psychiatry. 2018;175(8):765–73.
Article
PubMed
Google Scholar
Hui CL, Lam BS, Lee EH, Chan SK, Chang WC, Suen Y, et al. A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first-and multi-episode schizophrenia. Int Rev Psychiatry. 2019;31(5–6):441–59.
Article
PubMed
Google Scholar